The Closing of its $157 Million Series D Financing Round

(* atai Life sciences Announces NY, March 3, 2021 /PRNewswire/ — atai Life Sciences (“atai” or the “Company”), a clinical-stage company that is biopharmaceutical psychedelic and non-psychedelic compounds for various […]